- Trials with a EudraCT protocol (829)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
829 result(s) found for: covid-19.
Displaying page 8 of 42.
EudraCT Number: 2020-003722-23 | Sponsor Protocol Number: APHP200538 | Start Date*: 2020-10-02 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Efficacy of nicotine in preventing COVID-19 infection | |||||||||||||
Medical condition: Hospital staff (medical and non-medical), with COVID19 negative diagnosis (SARS-CoV2 serology and SARS-Cov2 PCR) working in contact with COVID-19 positive patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002249-40 | Sponsor Protocol Number: GNS561CLIQ0291 | Start Date*: 2020-06-30 | |||||||||||
Sponsor Name:Genoscience Pharma | |||||||||||||
Full Title: Cure COVID: A prospective, controlled, randomized study to compare the efficacy of GNS561 versus standard of care in patients with SARS-CoV-2 (COVID-19) infection. | |||||||||||||
Medical condition: COVID-19 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001362-35 | Sponsor Protocol Number: C4671034 | Start Date*: 2022-11-29 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, RANDOMIZED, DOUBLE-BLIND, 3-ARM STUDY TO INVESTIGATE NIRMATRELVIR/RITONAVIR IN NONHOSPITALIZED PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH SYMPTOMATIC... | |||||||||||||
Medical condition: SARS-CoV-2 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) BG (Completed) HU (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-006056-13 | Sponsor Protocol Number: D8850C00006 | Start Date*: 2022-07-26 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: Open-Label, Uncontrolled, Single dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of AZD7442 in Pediatric Participants Aged ≥ 29 weeks Gestational Age to < 18 years | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001721-31 | Sponsor Protocol Number: SPON-AK-0420 | Start Date*: 2020-05-01 | |||||||||||
Sponsor Name:Hampshire Hospitals NHS TRust | |||||||||||||
Full Title: Can a sinus rinse and mouth wash reduce viral load in COVID-19 positive individuals? | |||||||||||||
Medical condition: Covid-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001929-31 | Sponsor Protocol Number: ESCORPIO | Start Date*: 2020-06-16 |
Sponsor Name:Fundación Investigación Biomédica Hospital Ramón y Cajal | ||
Full Title: Controlled, randomized, non-blind trial on the usefulness of pioglitazone treatment in patients with type 2 diabetes mellitus and COVID-19. | ||
Medical condition: COVID-19 in patients with diabetes mellitus type 2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001769-19 | Sponsor Protocol Number: CVG01 | Start Date*: 2021-04-15 | |||||||||||
Sponsor Name:GUVAX (Gothenburg University Vaccine Research Institute) | |||||||||||||
Full Title: Immune response to SARS-CoV-2 in health care workers, previously infected subjects, and immunocompromised subjects, before and after Covid-19 vaccination: a phase IV trial | |||||||||||||
Medical condition: SARS-COV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001671-32 | Sponsor Protocol Number: STS-BDB001-04 | Start Date*: 2020-05-28 | |||||||||||
Sponsor Name:Staidson (Beijing) Biopharmaceutical Co., Ltd. and Beijing Defengrui Biological Technology Co., Ltd. | |||||||||||||
Full Title: A multi-center, open-label, randomized parallel controlled evaluation on the efficacy and safety of BDB-001 injection in the treatment of progressive severe COVID-19 in phase II | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001301-23 | Sponsor Protocol Number: APHP200387 | Start Date*: 2020-04-10 |
Sponsor Name:Assistance Publique - Hôpitaux de Paris | ||
Full Title: Efficacy of Addition of Naproxen in the Treatment of critically ill Patients Hospitalized for COVID-19 Infection / Enacovid Study | ||
Medical condition: COVID-19 Infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001605-23 | Sponsor Protocol Number: HUA-COVID-19 | Start Date*: 2020-05-29 |
Sponsor Name:Basque Health Service | ||
Full Title: Effectiveness of the combined treatment with hydroxycloroquine and azithromycin vs lopinavir/ritonavir + hydroxycloroquine in hospitalized patients with confirmed COVID-19 infection | ||
Medical condition: Covid-19 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001928-34 | Sponsor Protocol Number: HALT_Covid-19 | Start Date*: 2020-05-28 |
Sponsor Name:Capio S:t Görans Sjukhus | ||
Full Title: Inhalation of Ciclesonide for patients with Covid-19: A randomised open treatment study (HALT Covid-19). | ||
Medical condition: Covid-19 pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001296-33 | Sponsor Protocol Number: COMBAT-COVID-19 | Start Date*: 2020-05-06 | ||||||||||||||||
Sponsor Name:Section for Transfusion Medicine, Capital Region Blood bank, Copenhagen University Hospital | ||||||||||||||||||
Full Title: Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in patients with COVID-19 induced respiratory failure – a multicentre randomized, placebo-controlled, blinded, investigator-ini... | ||||||||||||||||||
Medical condition: COVID-19 induced respiratory failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001308-40 | Sponsor Protocol Number: INHIXACOVID19 | Start Date*: 2020-05-04 | ||||||||||||||||
Sponsor Name:ALMA MATER STUDIORUM UNIVERSITà DI BOLOGNA | ||||||||||||||||||
Full Title: Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19 | ||||||||||||||||||
Medical condition: Hospitalized adult patients with microbiologically confirmed moderate-severe COVID-19 infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004021-71 | Sponsor Protocol Number: NL.78693.041.21 | Start Date*: 2021-10-13 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: COrticosteroids for COVID-19 induced loss of Smell – COCOS trial | ||
Medical condition: Loss of smell after COVID-19 infection, persisting after 4 weeks | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003367-26 | Sponsor Protocol Number: MK4482-001 | Start Date*: 2020-11-18 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults with COVID-19 | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) GB (GB - no longer in EU/EEA) SE (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001662-11 | Sponsor Protocol Number: CINC424J12301 | Start Date*: 2020-05-05 |
Sponsor Name:Novartis Pharma AG | ||
Full Title: Phase 3 randomized, double-blind, placebo-controlled, multi-center study to assess the efficacy and safety of ruxolitinib in patients with COVID-19 associated cytokine storm (RUXCOVID) | ||
Medical condition: COVID-19 associated cytokine storm | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) FR (Completed) ES (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005887-70 | Sponsor Protocol Number: REMED | Start Date*: 2021-01-28 |
Sponsor Name:Fakultní nemocnice Brno | ||
Full Title: Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomized controlled trial | ||
Medical condition: Acute respiratory distress syndrome (ARDS) associated with COVID-19 pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006335-26 | Sponsor Protocol Number: Xe-long-COVID | Start Date*: 2022-03-04 | |||||||||||
Sponsor Name:Aarhus University | |||||||||||||
Full Title: Hyperpolarized xenon lung MRI in long-term COVID19 | |||||||||||||
Medical condition: Long COVID19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002447-22 | Sponsor Protocol Number: C4671031 | Start Date*: 2022-11-21 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, DOUBLE BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED NIRMATRELVIR/RITONAVIR COMPARED WITH PLACEBO/RITONAVIR FOR THE TREATMENT OF SEVERE COVID... | |||||||||||||
Medical condition: SARS-CoV-2 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001126-21 | Sponsor Protocol Number: 100423 | Start Date*: 2021-04-14 |
Sponsor Name:Division of Thoracic and Hyperbaric Surgery, Medical University Graz | ||
Full Title: Hyperbaric Oxygenation for patients with post-COVID-19 sequelae. Pilot study. | ||
Medical condition: Multiorgan symptoms after COVID-19 infection (Long COVID) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
